These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 5745605)

  • 1. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate].
    Gustafson A
    Lakartidningen; 1970 Dec; 67():Suppl IV:75+. PubMed ID: 5511954
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF
    Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
    Nordoy A; Gjone E
    Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of essential hyperlipidaemia.
    Fredrickson DS; Levy RI
    Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 13. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic trial of a hypolipemiant, 67-96 C, in tinnitus].
    Garcin M; Cagnol C
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(11):708-13. PubMed ID: 5757748
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term monitoring during clofibrate therapy.
    Vester JW; Sunder JH; Aarons JH; Danowski TS
    Clin Pharmacol Ther; 1970; 11(5):689-97. PubMed ID: 5460240
    [No Abstract]   [Full Text] [Related]  

  • 16. Diet and drug therapy for hyperlipoproteinemia.
    Maha GE
    Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
    [No Abstract]   [Full Text] [Related]  

  • 17. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet and drugs in the treatment of hyperlipidemias.
    Med Lett Drugs Ther; 1970 May; 12(10):42-4. PubMed ID: 5514225
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relations between lipid and carbohydrate metabolism. Treatment with a normo-lipemic agent: Clofibrate].
    Plauchu M; Gleize J; Garcia I; Mamelle ; Bussy L
    Lyon Med; 1969 Jun; 221(26):1537-46. PubMed ID: 5363734
    [No Abstract]   [Full Text] [Related]  

  • 20. [The value of lipavlon in diabetic retinopathy].
    François P; Belervacque A; Turut P
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.